Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Exchange Rate Effect (2021 - 2024)

Seres Therapeutics' Exchange Rate Effect history spans 4 years, with the latest figure at -$1000.0 for Q4 2024.

  • For Q4 2024, Exchange Rate Effect changed N/A year-over-year to -$1000.0; the TTM value through Sep 2024 reached $2000.0, up 300.0%, while the annual FY2024 figure was -$1000.0, 150.0% down from the prior year.
  • Exchange Rate Effect for Q4 2024 was -$1000.0 at Seres Therapeutics, down from $1000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $1000.0 in Q4 2022 and bottomed at -$2000.0 in Q3 2022.
  • The 4-year median for Exchange Rate Effect is -$1000.0 (2021), against an average of -$400.0.
  • The largest annual shift saw Exchange Rate Effect soared 200.0% in 2022 before it skyrocketed 150.0% in 2023.
  • A 4-year view of Exchange Rate Effect shows it stood at -$1000.0 in 2021, then skyrocketed by 200.0% to $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023, then tumbled by 200.0% to -$1000.0 in 2024.
  • Per Business Quant, the three most recent readings for MCRB's Exchange Rate Effect are -$1000.0 (Q4 2024), $1000.0 (Q3 2023), and $1000.0 (Q4 2022).